These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22691154)

  • 21. Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy.
    Kumar Sahoo S; Maddipatla S; Nageswara Rao Gajula S; Naiyaz Ahmad M; Kaul G; Nanduri S; Sonti R; Dasgupta A; Chopra S; Madhavi Yaddanapudi V
    Bioorg Med Chem; 2022 Jun; 64():116777. PubMed ID: 35487101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
    Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
    Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
    Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
    J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents.
    Elsaman T; Mohamed MS; Mohamed MA
    Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antituberculosis activity of new 2-quinoxalinecarbonitrile 1,4-di-N-oxides.
    Ortega MA; Sainz Y; Montoya ME; López De Ceráin A; Monge A
    Pharmazie; 1999 Jan; 54(1):24-5. PubMed ID: 9987794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis.
    Rakesh ; Bruhn DF; Scherman MS; Woolhiser LK; Madhura DB; Maddox MM; Singh AP; Lee RB; Hurdle JG; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE
    PLoS One; 2014; 9(2):e87909. PubMed ID: 24505329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
    Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
    Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naphthoquinones isolated from Diospyros anisandra exhibit potent activity against pan-resistant first-line drugs Mycobacterium tuberculosis strains.
    Uc-Cachón AH; Borges-Argáez R; Said-Fernández S; Vargas-Villarreal J; González-Salazar F; Méndez-González M; Cáceres-Farfán M; Molina-Salinas GM
    Pulm Pharmacol Ther; 2014 Feb; 27(1):114-20. PubMed ID: 23968826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against
    Komarova K; Vinogradova L; Lukin A; Zhuravlev M; Deniskin D; Chudinov M; Gureev M; Dogonadze M; Zabolotnykh N; Vinogradova T; Lavrova A; Yablonskiy P
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.
    Dos Santos Fernandes GF; de Souza PC; Moreno-Viguri E; Santivañez-Veliz M; Paucar R; Pérez-Silanes S; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Man Chin C; da Silva PB; Chorilli M; Solcia MC; Ribeiro CM; Silva CSP; Marino LB; Bosquesi PL; Hunt DM; de Carvalho LPS; de Souza Costa CA; Cho SH; Wang Y; Franzblau SG; Pavan FR; Dos Santos JL
    J Med Chem; 2017 Oct; 60(20):8647-8660. PubMed ID: 28968083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
    Zheng P; Somersan-Karakaya S; Lu S; Roberts J; Pingle M; Warrier T; Little D; Guo X; Brickner SJ; Nathan CF; Gold B; Liu G
    J Med Chem; 2014 May; 57(9):3755-72. PubMed ID: 24694175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.
    Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline.
    Darby CM; Nathan CF
    J Antimicrob Chemother; 2010 Jul; 65(7):1424-7. PubMed ID: 20435781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.
    Das U; Das S; Bandy B; Gorecki DK; Dimmock JR
    Eur J Med Chem; 2010 Oct; 45(10):4682-6. PubMed ID: 20705367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antitubercular activity of various nitro(triazole/imidazole)-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS
    Bioorg Med Chem; 2017 Nov; 25(21):6039-6048. PubMed ID: 28993106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.